Ugro Capital announces an acquisition

The NCLT Scheme does not provide a quantified pro-forma bridge for UGRO Capital’s AUM, net worth or CRAR. The three requested FY26/FY27 metrics were not separately disclosed in the scheme extracts, so the post-merger values and percentage changes cannot be confirmed.

• AUM: Not separately disclosed on a pro-forma basis. The Scheme’s stated rationale is consolidation of PCPL’s entire business with UGRO, with a higher secured-asset mix. PCPL was already UGRO’s wholly owned subsidiary. ^[1]
• Net worth: Not separately disclosed as a pro-forma post-amalgamation figure. The merger would primarily consolidate an existing subsidiary into the parent rather than introduce a new external shareholder group. ^[1]
• CRAR: Not separately disclosed on a pro-forma basis. UGRO’s reported CRAR was 21.17% as of 31 March 2026, comprising Tier 1 capital of 15.42% and Tier 2 capital of 5.75%; this is the reported company figure, not a calculated post-merger CRAR. ^[2]

Analytical implication: Since PCPL was already wholly owned, the merger is principally a legal and structural consolidation. A precise standalone pro-forma impact would require PCPL’s AUM, net worth, risk-weighted assets, eligible capital and merger-accounting adjustments. Those inputs are not disclosed in the cited material, so it would be inappropriate to infer whether CRAR rises or falls.

The exact share-exchange ratio could not be confirmed from the scheme and approval disclosures cited here. UGRO’s shareholders approved the amalgamation on 22 September 2026, but the approval announcement does not state the ratio or the number of UGRO shares to be issued ^[3].

Accordingly, the implied valuation of Profectus Capital cannot be calculated defensibly, and no comparison with its latest audited book value can be made from the disclosed figures. The required inputs are:

• the approved exchange ratio or stated merger consideration;
• the number of Profectus shares covered by the ratio; and
• Profectus Capital’s latest audited net worth/book value in the scheme financials.

UGRO’s annual-report disclosure of aggregate acquisition consideration of Rs 13,986.0 lakhs relates to the December 2025 acquisition of Profectus; it should not be treated as the amalgamation’s implied valuation without explicit confirmation in the scheme document ^[2].

The integration appears to improve UGRO Capital’s secured-asset mix, but the explanatory-statement details do not support a quantified conclusion on either sectoral concentration or portfolio yield. The stated rationale is that the combined entity will have “higher secured assets,” supporting the Emerging Market and Embedded Finance businesses ^[1].

• Sectoral concentration: A pro-forma concentration shift cannot be calculated without the pre-merger UGRO and Profectus sector weights, followed by a loan-book-weighted combination. Accordingly, it is not possible to establish whether exposure to any particular sector increased or declined. The portfolio-level sector concentration for FY26/FY27 was not separately disclosed.
• Yield profile: The higher secured-asset mix may alter the risk-pricing composition of the book, but it does not by itself establish whether the blended yield will rise or fall. That requires product-wise yields, average lending rates, or portfolio yields for both entities; those figures were not separately disclosed.
• What does change directionally: The transaction shifts UGRO toward a larger secured lending platform and away from assessing growth purely through incremental unsecured or less-secured exposure. That is primarily an asset-quality and risk-mix change, not demonstrable evidence of yield expansion.
• Analytical limit: Without sector-wise loan balances and yields before and after consolidation, any claim of reduced concentration, higher yield, or lower yield would be speculative.